Literature DB >> 10780521

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.

M V Jacobs1, D Zielinski, C J Meijer, R P Pol, F J Voorhorst, F A de Schipper, A P Runsink, P J Snijders, J M Walboomers.   

Abstract

The efficacy of four methods to recover DNA from Papanicolaou (Pap)-stained archival cervical smears for optimal detection of human papillomavirus (HPV) DNA by GP5+/bioGP6+ polymerase chain reaction (PCR) was investigated. Two of the methods were based on proteinase K treatment and two based on treatment with guanidinium thiocyanate (GTC). The quality of the DNA as measured by PCR assays amplifying different sizes of the beta-globin gene appeared to be superior for the GTC-based assays. Using competitive beta-globin PCR assays, one of the GTC-based, assays, provisionally named High Pure PCR Template Preparation (HPPTP) assay, yielded by far the highest quantity of amplifiable DNA. It allowed the recovery of 2.2 x 10(5) to 3 x 10(5) genome equivalents in smears containing 5 x 10(5) to 20 x 10(5) nucleated cells, indicating a mean efficiency of 26% (range of 15-44%). In contrast, the other methods revealed markedly lower efficiencies varying from 1% to 10%. The use of the HPPTP assay as a reliable processing procedure was validated by demonstrating a complete agreement in HPV detection and 93% agreement in HPV typing between 39 archival Pap-stained and paired fresh-frozen cervical smears. This method was applied to 40 archival smears from ten cervical cancer patients (selected from a group of 200 patients) which had a history of 3-6 smears with the first smear being Pap 1 or 2 taken at least 5 years before cancer was diagnosed. The average time period between the first Pap 1/2 smear that contained the same HPV type as in the corresponding carcinoma and diagnosis of cervical cancer was 12.0 +/- 2.9 years. All subsequent smears were invariably positive for the same HPV type which was also found in the cervical cancer biopsy. In conclusion, the HPPTP assay provides a reliable and efficient means to extract DNA from Pap-stained archival cervical smears for the detection of HPV DNA by PCR and would be the method of choice for future HPV analysis of archival Pap-stained cervical smears.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780521      PMCID: PMC2363381          DOI: 10.1054/bjoc.1999.1128

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Predicting mortality from cervical cancer after negative smear test results.

Authors:  G J van Oortmarssen; J D Habbema; M van Ballegooijen
Journal:  BMJ       Date:  1992-08-22

2.  Isolation of DNA from archival Papanicolaou stained cytological smears using a simple salting-out procedure.

Authors:  M Poljak; J Barlic; K Seme; T Avsic-Zupanc; A Zore
Journal:  Clin Mol Pathol       Date:  1995-02

3.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Authors:  M V Jacobs; P J Snijders; A J van den Brule; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

5.  HPV typing and testing in gynaecological pathology: has the time come?

Authors:  C J Meijer; T J Helmerhorst; L Rozendaal; J C van der Linden; F J Voorhorst; J M Walboomers
Journal:  Histopathology       Date:  1998-07       Impact factor: 5.087

6.  Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears.

Authors:  M Puranen; S Saarikoski; K Syrjänen; S Syrjänen
Journal:  Acta Cytol       Date:  1996 May-Jun       Impact factor: 2.319

7.  The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.

Authors:  A J Remmink; J M Walboomers; T J Helmerhorst; F J Voorhorst; L Rozendaal; E K Risse; C J Meijer; P Kenemans
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396

8.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

9.  Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction.

Authors:  A M de Roda Husman; P J Snijders; H V Stel; A J van den Brule; C J Meijer; J M Walboomers
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

10.  A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings.

Authors:  M V Jacobs; J M Walboomers; J van Beek; F J Voorhorst; R H Verheijen; C J Meijer; A J van den Brule; T J Helmerhorst; P J Snijders
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

View more
  9 in total

1.  Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; L H Jaspars; F J Voorhorst; R H M Verheijen; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

2.  In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology.

Authors:  M van Seters; F J W ten Kate; M van Beurden; R H M Verheijen; C J L M Meijer; M P M Burger; T J M Helmerhorst
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

3.  Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?

Authors:  Björn Strander; Walter Ryd; Keng-Ling Wallin; Bengt Wärleby; Biying Zheng; Ian Milsom; Baback Gharizadeh; Nader Pourmand; Agneta Andersson-Ellström
Journal:  Eur J Cancer       Date:  2007-07-05       Impact factor: 9.162

4.  Cervical human papillomavirus screening among older women.

Authors:  Matthew J Grainge; Rashmi Seth; Li Guo; Keith R Neal; Carol Coupland; Paul Vryenhoef; Jane Johnson; David Jenkins
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

5.  The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.

Authors:  S Bulk; J Berkhof; L Rozendaal; N C Fransen Daalmeijer; M Gök; F A de Schipper; F J van Kemenade; P J F Snijders; C J L M Meijer
Journal:  Br J Cancer       Date:  2007-03-20       Impact factor: 7.640

6.  Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case-control study in the UK.

Authors:  M J Grainge; R Seth; C Coupland; L Guo; T Rittman; P Vryenhoef; J Johnson; D Jenkins; K R Neal
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

7.  HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.

Authors:  G D Zielinski; P J Snijders; L Rozendaal; F J Voorhorst; H C van der Linden; A P Runsink; F A de Schipper; C J Meijer
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

8.  High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; P D Bezemer; F J Voorhorst; C J L M Meijer
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

9.  Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.

Authors:  Abida Siddiqa; Maidah Zainab; Ishtiaq Qadri; Muhammad Faraz Bhatti; Joanna L Parish
Journal:  Viruses       Date:  2014-07-17       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.